Alireza Ghaffarieh is an Ophthalmology physician. OpenAlex indexes 28 publications with 335 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1309 E Ridge Rd Ste 1
Mcallen, TX 785031518
Telephone
956-631-8875Provider last certified this registry record 12 Jan 2026.
Industry payments
17 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Sight Sciences, Inc.Program year20241 payment
- Oyster Point Pharma, Inc.Program year20235 payments
- Astellas Pharma US IncProgram year20232 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
68.6%Prostaglandin Analog27.4%Latanoprost95%Lumigan5%Part D≥408 patientsCorticosteroid18.9%Prednisolone Acetate98%Fluorometholone2%Part D≥489 patients+ 8 more classes in this area
Anti-infectives
15.6%Fluoroquinolone Antibacterial12.9%Moxifloxacin100%Part D≥348 patientsHerpesvirus Nucleoside Analog DNA Polymerase Inhibitor1.1%Valacyclovir100%Part D≥24 patients+ 2 more classes in this area
Musculoskeletal
7.7%Cyclooxygenase Inhibitor7.7%Ketorolac Tromethamine100%Part D≥217 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Overcoming Antimicrobial Resistance in Bacterial Keratitis With an Antibiotic-Eluting Contact Lens
Investigative Ophthalmology & Visual Science
2025 - Overcoming Antimicrobial Resistance in Bacterial Keratitis with an Antibiotic-Eluting Contact Lens
SSRN Electronic Journal
2024 - An <i>ex vivo</i> human precision-cut lung slice platform provides insight into SARS-CoV-2 pathogenesis and antiviral drug efficacy
bioRxiv (Cold Spring Harbor Laboratory)
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Ali Bijani
Babol University of Medical Sciences
Hamid Asayesh
Ayatollah Boroujerdi University
John J. Huang
Isfahan University of Medical Sciences
Fotis Topouzis
National University of Singapore
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”